A Review of Pseudomyxoma Peritonei: Insights Into Diagnosis, Management, and Prognosis

Siddhi Shringi1, Anil K Agrawal1, Pravin Gadkari1

  • 1Pathology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.

Cureus
|June 28, 2024
PubMed

Insights

Pseudomyxoma peritonei (PMP) is a rare condition of mucinous ascites. This review covers PMP diagnosis, management, and prognosis, highlighting multidisciplinary care and new therapies for better patient outcomes.

Area of Science:

  • Gastroenterology
  • Oncology
  • Surgical Oncology

Background:

  • Pseudomyxoma peritonei (PMP) is a rare clinical syndrome.
  • Characterized by mucinous ascites, often from appendiceal tumors.
  • PMP presents diagnostic and management challenges due to its nature.

Purpose of the Study:

  • To provide insights into PMP diagnosis, management, and prognosis.
  • To synthesize current evidence and emerging trends in PMP care.
  • To discuss challenges and opportunities in PMP management.

Main Methods:

  • Comprehensive literature review.
  • Synthesis of current evidence and emerging trends.
  • Discussion of clinical practice recommendations.

Main Results:

  • PMP diagnosis and management are complex.
  • A multidisciplinary approach and specialized care are crucial.
  • Advances in surgery, chemotherapy, and therapies offer hope.

Conclusions:

  • PMP requires specialized, multidisciplinary care.
  • Ongoing research and therapeutic advances are improving outcomes.
  • Improved quality of life for PMP patients is a key goal.

Related Concept Videos

Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
54
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
84
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
118
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
74
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
162